Cargando…
Cancer pharmacogenetics
The large number of active combination chemotherapy regimens for most cancers has led to the need for better information to guide the ‘standard’ treatment for each patient. In an attempt to individualise therapy, pharmacogenetics and pharmacogenomics (a polygenic approach to pharmacogenetic studies)...
Autores principales: | Marsh, S, McLeod, H L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395337/ https://www.ncbi.nlm.nih.gov/pubmed/14710198 http://dx.doi.org/10.1038/sj.bjc.6601487 |
Ejemplares similares
-
Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism
por: Zimdahl Kahlin, Anna, et al.
Publicado: (2020) -
Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022) -
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
por: Ridge, S. A., et al.
Publicado: (1998) -
Mathematical models of targeted cancer therapy
por: Abbott, L H, et al.
Publicado: (2006) -
When less may be more: calorie restriction and response to cancer therapy
por: O’Flanagan, Ciara H., et al.
Publicado: (2017)